61 – 70 of 116
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Safety of pancreatic resection in the elderly : a retrospective analysis of 556 patients
(
- Contribution to journal › Article
-
Mark
Organ Preservation and Reperfusion Influence on Outcome after Heart Transplantation
2016) 36th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation In The Journal of Heart and Lung Transplantation 35(4 Suppl). p.193-193(
- Contribution to journal › Published meeting abstract
-
Mark
Donor Age Associated with Short-Term and Recipient Age Associated with Long-Term Mortality in Heart Transplantation
2016) 36th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation In The Journal of Heart and Lung Transplantation 35(4 Suppl). p.114-115(
- Contribution to journal › Published meeting abstract
-
Mark
Induction Immunosuppression Strategies and Long-Term Outcomes after Heart Transplantation
2016) 36th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation In The Journal of Heart and Lung Transplantation 35(4 Suppl). p.62-63(
- Contribution to journal › Published meeting abstract
- 2015
-
Mark
The International Heart Transplant Survival Algorithm (IHTSA): A New Model to Improve Organ Sharing and Survival.
(
- Contribution to journal › Article
-
Mark
ABO-Identical Blood Group Matching Has No Survival Benefit for AB Heart Transplant Recipients.
(
- Contribution to journal › Article
-
Mark
Outcomes after ABO-incompatible heart transplantation in adults: A registry study.
(
- Contribution to journal › Article
-
Mark
Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer.
(
- Contribution to journal › Article
-
Mark
Protein deep sequencing applied to biobank samples from patients with pancreatic cancer.
(
- Contribution to journal › Article
-
Mark
Comparison of Basiliximab and Anti-Thymocyte Globulin as Induction Therapy in Pediatric Heart Transplantation: A Survival Analysis.
(
- Contribution to journal › Article